Emergence of Crohn's disease in Juvenile Idiopathic Arthritis during treatment with etanercept: a causal link or a mere coincidence?

被引：0
|
作者：
Oikonomou, Konstantinos A. [1 ]
Kapsoritakis, Andreas N. [1 ]
Tsiopoulos, Fotios D. [1 ]
Tsikouras, Antonios N. [1 ]
Potamianos, Spyros [1 ]
机构：
[1] Univ Thessaly, Dept Gastroenterol, Sch Med, Thessaloniki, Greece
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2010年 / 19卷 / 03期
关键词：
NECROSIS-FACTOR-ALPHA; ANKYLOSING-SPONDYLITIS; ONSET;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [41] Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
    van Dijken, Trudy D.
    Vastert, Sebastiaan J.
    Gerloni, Valeria M.
    Pontikaki, Irene
    Linnemann, Kristina
    Girschick, Hermann
    Armbrust, Wineke
    Minden, Kirsten
    Prince, Femke H. M.
    Kokke, Freddy T. M.
    Nieuwenhuis, Edward E. S.
    Horneff, Gerd
    Wulffraat, Nico M.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1441 - 1446
  • [42] PREDICTORS OF ACHIEVEMENT OF INACTIVE DISEASE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH ETANERCEPT
    Solari, N.
    Palmisani, E.
    Consolaro, A.
    Pistorio, A.
    Lanni, S.
    Dalpra, S.
    Schiappapietra, B.
    Bracciolini, G.
    Frisina, A.
    Martini, A.
    Ravelli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 53 - 53
  • [43] Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
    Murdaca, Giuseppe
    Negrini, Simone
    Magnani, Ottavia
    Penza, Elena
    Pellecchio, Marco
    Gulli, Rossella
    Mandich, Paola
    Puppo, Francesco
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 417 - 431
  • [44] Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis
    Tynjala, Pirjo
    Lindahl, Paivi
    Honkanen, Visa
    Lahdenne, Pekka
    Kotaniemi, Kaisu
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 548 - 550
  • [45] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
    Southwood, Taunton R.
    Foster, Helen E.
    Davidson, Joyce E.
    Hyrich, Kimme L.
    Cotter, Catherine B.
    Wedderburn, Lucy R.
    Hull, Richard G.
    Venning, Helen E.
    Rahman, Joy K.
    Cummins, Carole L.
    RHEUMATOLOGY, 2011, 50 (01) : 189 - 195
  • [46] A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study
    Schmeling, H
    Mathony, K
    John, V
    Keysser, G
    Burdach, S
    Horneff, G
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (04) : 410 - 412
  • [47] Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis
    Vojvodich, Paola Fernandez
    Hansen, Jes B.
    Andersson, Ulf
    Savendahl, Lars
    Hagelberg, Stefan
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2481 - 2485
  • [48] Experience in the treatment with etanercept in patients with juvenile idiopathic arthritis under 4 years
    Calvo, I.
    Lopez, B.
    Marco, A.
    Maneiro, J. R.
    Diez, C.
    Espino-Lorenzo, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 387 - 387
  • [49] Development of Crohn disease during anti-TNF-α therapy in a child with juvenile idiopathic arthritis
    Ruemmele, FM
    Prieur, AM
    Talbotec, C
    Goulet, O
    Schmitz, J
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (02): : 203 - 206
  • [50] Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis
    Mene, P.
    Franeta, A. -J.
    Conti, G.
    Stoppacciaro, A.
    Chimenz, R.
    Fede, A.
    Gallizzi, R.
    Fede, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : 91 - 93
12345